Skip to main content

Find Clinical Trials

Home
Conditions
Sclerotic Graft Versus Host Disease

Clinical trial condition

Sclerotic Graft Versus Host Disease

Explore clinical trials studying Sclerotic Graft Versus Host Disease. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Sclerotic Graft Versus Host Disease trial results

Completed

Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease

NCT00702689

Conditions: Graft vs Host Disease, Imatinib Mesylate, Immune System Diseases, +1 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details